148 filings
Page 4 of 8
8-K
ttd3cg 22x2
4 Nov 21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
cyl86cyxs9df4qiqo
29 Sep 21
Other Events
5:13pm
8-K
0ijzjqx78c18cn
5 Aug 21
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:14pm
8-K
821n54t
28 Jun 21
Other Events
6:07am
8-K
6lj8zajvj cl
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
kntf5k9
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
nl46i h449
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
13pj0rivv1 jhji
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
pvqqng
13 Apr 21
Other Events
4:06pm
DEFA14A
ax67qmt
6 Apr 21
Additional proxy soliciting materials
4:07pm
8-K
adswp0bg3pw0cpvgmfv5
31 Mar 21
Other Events
4:05pm
8-K
bn32kebo1ef75am75 nw
30 Mar 21
Other Events
6:07am
S-8
kpfy0m a5
25 Feb 21
Registration of securities for employees
5:30pm
8-K
rdvax7qmeew8yyzfe0a
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
cofh16t
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
6mkg3116kkhigrcy3c
28 Jan 21
Other Events
4:05pm